Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning models can be trained to predict chronic diseases such as dementia using electronic medical record (EMR) data, according to a new study published in Artificial Intelligence in Medicine.
Oncopole, a Montreal-based research center, announced that five teams won the Onco-Tech Competition and will receive a total of $1.97 ($2.6 million CAD) in funding.
Civica Rx, the not-for-profit drug company startup created by a group of hospitals and health systems to reduce drug shortages, is prepared to ship its first eight injectable medicines.
Humana is launching two new partnerships in four states to better care for its Medicare Advantage and commercially insured members who have kidney care.
Amazon’s online pharmacy business, PillPack, has integrated with Blue Cross Blue Shield of Massachusetts to help members of the health plan manage their medications.
Deep learning models can improve the detection of attention deficit hyperactivity disorder (ADHD), according to new findings published in Radiology: Artificial Intelligence.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.